Familial abnormalities of endocannabinoid signaling in schizophrenia
Objectives: Epidemiological and experimental evidence suggests that the endocannabinoid system plays a pathophysiological role in schizophrenia. This is reflected by elevated cerebrospinal levels of the endocannabinoid anandamide in schizophrenia and its initial prodromal states.Methods: We analyzed...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
The world journal of biological psychiatry
Year: 2018, Jahrgang: 20, Heft: 2, Pages: 117-125 |
| ISSN: | 1814-1412 |
| DOI: | 10.1080/15622975.2018.1449966 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1080/15622975.2018.1449966
|
| Verfasserangaben: | Dagmar Koethe, Franziska Pahlisch, Martin Hellmich, Cathrin Rohleder, Juliane K. Mueller, Andreas Meyer-Lindenberg, E. Fuller Torrey, Daniele Piomelli & F. Markus Leweke |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1666557145 | ||
| 003 | DE-627 | ||
| 005 | 20220816163526.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190531r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/15622975.2018.1449966 |2 doi | |
| 035 | |a (DE-627)1666557145 | ||
| 035 | |a (DE-599)KXP1666557145 | ||
| 035 | |a (OCoLC)1341225947 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Köthe, Dagmar |d 1972- |e VerfasserIn |0 (DE-588)123827566 |0 (DE-627)085465275 |0 (DE-576)293896844 |4 aut | |
| 245 | 1 | 0 | |a Familial abnormalities of endocannabinoid signaling in schizophrenia |c Dagmar Koethe, Franziska Pahlisch, Martin Hellmich, Cathrin Rohleder, Juliane K. Mueller, Andreas Meyer-Lindenberg, E. Fuller Torrey, Daniele Piomelli & F. Markus Leweke |
| 264 | 1 | |c 2019 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 31.05.2019 | ||
| 500 | |a Published online: 22 Mar 2018 | ||
| 520 | |a Objectives: Epidemiological and experimental evidence suggests that the endocannabinoid system plays a pathophysiological role in schizophrenia. This is reflected by elevated cerebrospinal levels of the endocannabinoid anandamide in schizophrenia and its initial prodromal states.Methods: We analyzed plasma concentrations of anandamide, 2-arachidonoyl-sn-glycerol, palmitoylethanolamide and oleoylethanolamide from 25 twin pairs discordant for schizophrenia, six discordant for bipolar disorder and eight healthy twin pairs to determine hereditary traits.Results: Twin pairs discordant for schizophrenia or bipolar disorder had significantly higher levels of anandamide and palmitoylethanolamide compared to healthy twins (both P < 0.002). Non-affected twins discordant for schizophrenia, who developed a psychotic disorder within 5 years follow-up showed lower anandamide (P = 0.042) and 2-arachidonoyl-sn-glycerol levels (P = 0.049) than twins who remained healthy.Conclusions: We suggest that the protective upregulation of endocannabinoid signalling reflects either a hereditary trait or mirrors a modulating response to genetically influenced cerebral function involving, e.g., other neurotransmitters or energy metabolism. | ||
| 534 | |c 2018 | ||
| 650 | 4 | |a anandamide (AEA) | |
| 650 | 4 | |a endocannabinoids | |
| 650 | 4 | |a genetic risk | |
| 650 | 4 | |a monozygotic twins | |
| 650 | 4 | |a Psychosis | |
| 700 | 1 | |a Pahlisch, Franziska |e VerfasserIn |0 (DE-588)1126584800 |0 (DE-627)881141755 |0 (DE-576)484576089 |4 aut | |
| 700 | 1 | |a Rohleder, Cathrin |e VerfasserIn |0 (DE-588)1023876469 |0 (DE-627)718655214 |0 (DE-576)367576775 |4 aut | |
| 700 | 1 | |a Meyer-Lindenberg, Andreas |d 1965- |e VerfasserIn |0 (DE-588)1029137390 |0 (DE-627)732483069 |0 (DE-576)376589876 |4 aut | |
| 700 | 1 | |a Leweke, F. Markus |e VerfasserIn |0 (DE-588)1052094287 |0 (DE-627)787796859 |0 (DE-576)407845941 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The world journal of biological psychiatry |d Abingdon : Taylor & Francis Group, 2000 |g 20(2019), 2, Seite 117-125 |h Online-Ressource |w (DE-627)474385051 |w (DE-600)2170223-8 |w (DE-576)27773293X |x 1814-1412 |7 nnas |a Familial abnormalities of endocannabinoid signaling in schizophrenia |
| 773 | 1 | 8 | |g volume:20 |g year:2019 |g number:2 |g pages:117-125 |g extent:9 |a Familial abnormalities of endocannabinoid signaling in schizophrenia |
| 856 | 4 | 0 | |u https://doi.org/10.1080/15622975.2018.1449966 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1080/15622975.2018.1449966 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190531 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1052094287 |a Leweke, F. Markus |m 1052094287:Leweke, F. Markus |d 60000 |e 60000PL1052094287 |k 0/60000/ |p 9 |y j | ||
| 998 | |g 1029137390 |a Meyer-Lindenberg, Andreas |m 1029137390:Meyer-Lindenberg, Andreas |d 60000 |e 60000PM1029137390 |k 0/60000/ |p 6 | ||
| 998 | |g 1023876469 |a Rohleder, Cathrin |m 1023876469:Rohleder, Cathrin |d 60000 |e 60000PR1023876469 |k 0/60000/ |p 4 | ||
| 998 | |g 1126584800 |a Pahlisch, Franziska |m 1126584800:Pahlisch, Franziska |d 60000 |e 60000PP1126584800 |k 0/60000/ |p 2 | ||
| 998 | |g 123827566 |a Köthe, Dagmar |m 123827566:Köthe, Dagmar |p 1 |x j | ||
| 999 | |a KXP-PPN1666557145 |e 3480346006 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"part":{"extent":"9","year":"2019","pages":"117-125","text":"20(2019), 2, Seite 117-125","volume":"20","issue":"2"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisherPlace":"Abingdon ; London [u.a.]"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Familial abnormalities of endocannabinoid signaling in schizophreniaThe world journal of biological psychiatry","note":["Gesehen am 01.09.15"],"id":{"zdb":["2170223-8"],"eki":["474385051"],"issn":["1814-1412"]},"title":[{"title_sort":"world journal of biological psychiatry","title":"The world journal of biological psychiatry"}],"pubHistory":["1.2000 -"],"recId":"474385051"}],"person":[{"family":"Köthe","roleDisplay":"VerfasserIn","given":"Dagmar","display":"Köthe, Dagmar","role":"aut"},{"given":"Franziska","display":"Pahlisch, Franziska","role":"aut","roleDisplay":"VerfasserIn","family":"Pahlisch"},{"roleDisplay":"VerfasserIn","family":"Rohleder","role":"aut","display":"Rohleder, Cathrin","given":"Cathrin"},{"given":"Andreas","display":"Meyer-Lindenberg, Andreas","role":"aut","family":"Meyer-Lindenberg","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Leweke","given":"F. Markus","display":"Leweke, F. Markus","role":"aut"}],"name":{"displayForm":["Dagmar Koethe, Franziska Pahlisch, Martin Hellmich, Cathrin Rohleder, Juliane K. Mueller, Andreas Meyer-Lindenberg, E. Fuller Torrey, Daniele Piomelli & F. Markus Leweke"]},"physDesc":[{"extent":"9 S."}],"language":["eng"],"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 31.05.2019","Published online: 22 Mar 2018"],"id":{"doi":["10.1080/15622975.2018.1449966"],"eki":["1666557145"]},"title":[{"title":"Familial abnormalities of endocannabinoid signaling in schizophrenia","title_sort":"Familial abnormalities of endocannabinoid signaling in schizophrenia"}],"recId":"1666557145"} | ||
| SRT | |a KOETHEDAGMFAMILIALAB2019 | ||